OYST
Oyster Point Pharma Inc
Price:  
11.17 
USD
Volume:  
2,091,430.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

OYST WACC - Weighted Average Cost of Capital

The WACC of Oyster Point Pharma Inc (OYST) is 7.8%.

The Cost of Equity of Oyster Point Pharma Inc (OYST) is 8.55%.
The Cost of Debt of Oyster Point Pharma Inc (OYST) is 7.00%.

Range Selected
Cost of equity 7.00% - 10.10% 8.55%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 7.00% - 7.00% 7.00%
WACC 6.6% - 8.9% 7.8%
WACC

OYST WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.68 0.93
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.00% 10.10%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.3 0.3
Cost of debt 7.00% 7.00%
After-tax WACC 6.6% 8.9%
Selected WACC 7.8%